Table 2.
LGI3 immunohistochemical staining of vitiligo patients before and after phototherapy, and controls
Immunohistochemical staining | Studied group (N=60) | Test of Significance | p-value | |||||
---|---|---|---|---|---|---|---|---|
Expression | NO | % | NO | % | NO | % | T1=χ2=8.29 | P1=0.003* |
Positive | 20 | 100 | 27 | 67.5 | 37 | 92.5 | T2=Mc Nemar χ2=10.58 | P2=0.001* |
Negative | 0 | 0.0 | 13 | 32.5 | 3 | 7.5 | T3= χ2=1.85 | P3=0.554 |
Localization | ||||||||
Cytoplasmic | 18 | 90 | 24 | 88.9 | 31 | 83.8 | T1= χ2=0.83 | P1=0.659 |
Membranous | 0 | 0 | 1 | 3.7 | 1 | 2.7 | T2=MH=0.447 | P2=0.655 |
Membrano-cytoplasmic | 2 | 10 | 2 | 7.4 | 5 | 13.5 | T3= χ2=0.73 | P3=0.694 |
Intensity | ||||||||
Mild | 10 | 50.0 | 22 | 81.5 | 18 | 48.6 | T1= χ2=8.65 | P1=0.013* |
Moderate | 5 | 25.0 | 5 | 18.5 | 14 | 37.8 | T2=MH=2.99 | P2=0.003* |
Strong | 5 | 25.0 | 0 | 0.0 | 5 | 13.5 | T3= χ21.62 | P3=0.444 |
Distribution | T1= χ2=0.366 | P1=0.545 | ||||||
Patchy | 14 | 70.0 | 21 | 77.8 | 20 | 54.05 | T2=Mc Nemar χ2=6.50 | P2=0.011* |
Diffuse | 6 | 30.0 | 6 | 22.2 | 17 | 45.9 | T3= χ2=1.37 | P3=0.242 |
Percentage | ||||||||
Mean ± SD | 40.25±26.83 | 18.22±18.44 | 39.07±24.89 | T1=U=116.00 | P1=0.001* | |||
Range | 10.0-85.0 | 2.0-70.0 | 2.0-95.0 | T2=Wilcoxon signed rank=4.29 | P2=0.001* | |||
Median | 30.0 | 10.0 | 30.0 | T3=U=0.528 | P3=0.597 | |||
H score | ||||||||
Mean ± SD | 89.75±94.79 | 25.26±31.03 | 74.11±71.96 | T1=U=3.39 | P1=0.001* | |||
Range | 10.0-255.0 | 2.0-120.0 | 2.0-240.0 | T2=Wilcoxon signed rank =4.38 | P2=0.001* | |||
Median | 40.0 | 10.0 | 45.0 | T3=U=0.570 | P3=0.569 |
T1: test of significance for comparison between cases before treatment and controls; T2: test of significance for comparison between cases before and after treatment; T3: test of significance for comparison between cases after treatment and controls; P1: p-value of comparison between cases before treatment and controls; P2: p-value of comparison between cases before and after treatment; P3: p-value of comparison between cases after treatment and controls;
Significant.